PDFs of the poster presentations will be made available on Denali’s corporate website under the Investor Events section on February 22, 2023, at approximately 3:00 PM Eastern Time. PDFs of the oral ...
Hunter syndrome (MPS II) presentations will include analysis from continued follow-up of Phase 1/2 data for tividenofusp alfa (DNL310), currently under FDA Priority Review Preliminary data from Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results